As part of a May 15 reorganization, US FDA has established a new pharmaceutical inspectorate in its Office of Regulatory Affairs and apportioned the inspectorate's staff among four domestic regional divisions, one foreign division and one program division.
The reorganization, called program alignment, enables the agency's field organization to specialize by type of product. Investigators will no long...






